The upregulation of cGMP–PKG and Gap junction signaling pathways, and the downregulation of the ECM receptor interaction signaling pathway, were considered to be beneficial to the improvement of diabetes nephropathy [21,22,23,24]. Here, PRKG1 is linked to diabetic kidney disease.